Last 12 months
Inside the activity.
1 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 7 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 1 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2024 Filed Feb 29, 2024 23:58 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 745 | $20.00 | $14,900.00 |
DisclosureSEC source: 0000950170-24-023406 · ownership.xml · nonDerivative · entry 1 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 450,735 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022. Read SEC document |
| February 12, 2024 Filed Feb 15, 2024 02:00 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 1,501 | $20.00 | $30,020.00 |
DisclosureSEC source: 0000950170-24-015559 · ownership.xml · nonDerivative · entry 1 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 451,480 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022. Read SEC document |
| February 07, 2024 Filed Feb 10, 2024 00:26 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 9,587 | $18.09 | $173,466.22 |
DisclosureSEC source: 0000950170-24-013474 · ownership.xml · nonDerivative · entry 1 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 452,981 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $18.00 to $18.48. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| February 06, 2024 Filed Feb 7, 2024 01:23 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 15,413 | $18.09 | $278,827.34 |
DisclosureSEC source: 0000950170-24-011880 · ownership.xml · nonDerivative · entry 4 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 462,568 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022. F4 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $18.00 to $18.44. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 17:09 UTC |
Boxer Capital, LLCSee Remarks
Boxer Asset Management Inc.See Remarks
LEWIS JOSEPHSee Remarks
MVA Investors, LLCSee Remarks
Davis Aaron I.See Remarks
|
GrantWarrant (right to purchase) · Derivative | 705,280 | $13.01 Strike: $0.00 | $9,174,987.52 |
DisclosureSEC source: 0000895345-24-000035 · form4.xml · derivative · entry 3 Boxer Capital, LLC · CIK 0001465837 · See Remarks Boxer Asset Management Inc. · CIK 0001465836 · See Remarks LEWIS JOSEPH · CIK 0001015747 · See Remarks MVA Investors, LLC · CIK 0001468223 · See Remarks Davis Aaron I. · CIK 0001465914 · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 705,280 Underlying: Common Stock · 705,280 shares Expires not disclosed F3 · derivative.exercise_date: These Warrants are exercisable immediately (subject to any applicable beneficial ownership limitation) and do not have an expiration date. F3 · derivative.expiration_date: These Warrants are exercisable immediately (subject to any applicable beneficial ownership limitation) and do not have an expiration date. F2 · ownership.direct: These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"). Boxer Asset Management Inc. ("Boxer Management") is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Management. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 17:09 UTC |
Boxer Capital, LLCSee Remarks
Boxer Asset Management Inc.See Remarks
LEWIS JOSEPHSee Remarks
MVA Investors, LLCSee Remarks
Davis Aaron I.See Remarks
|
GrantCommon Stock | 63,412 | $13.01 | $824,990.12 |
DisclosureSEC source: 0000895345-24-000035 · form4.xml · nonDerivative · entry 1 Boxer Capital, LLC · CIK 0001465837 · See Remarks Boxer Asset Management Inc. · CIK 0001465836 · See Remarks LEWIS JOSEPH · CIK 0001015747 · See Remarks MVA Investors, LLC · CIK 0001468223 · See Remarks Davis Aaron I. · CIK 0001465914 · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 85,939 F1 · ownership.nature: These securities are owned directly by MVA Investors, LLC ("MVA Investors"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 22:16 UTC |
RA CAPITAL MANAGEMENT, L.P.Director · 10% owner
RA Capital Healthcare Fund LPDirector · 10% owner
RA Capital Nexus Fund, L.P.Director · 10% owner
Kolchinsky PeterDirector · 10% owner
Shah Rajeev M.Director · 10% owner
|
GrantPre-Funded Warrants (Right to Buy) · Derivative | 1,538,457 | $13.01 Strike: $0.00 | $20,013,787.11 |
DisclosureSEC source: 0001415889-24-003043 · form4-02082024_100255.xml · derivative · entry 4 RA CAPITAL MANAGEMENT, L.P. · CIK 0001346824 · Director · 10% owner RA Capital Healthcare Fund LP · CIK 0001315082 · Director · 10% owner RA Capital Nexus Fund, L.P. · CIK 0001780117 · Director · 10% owner Kolchinsky Peter · CIK 0001384859 · Director · 10% owner Shah Rajeev M. · CIK 0001619841 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 1,538,457 Underlying: Common Stock · 1,538,457 shares Expires not disclosed F5 · derivative.exercise_date: The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise. F5 · derivative.expiration_date: The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise. F1 · ownership.nature: These securities are held directly by RA Capital Healthcare Fund, L.P. (the "Fund"). F2 · ownership.nature: RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund, RA Capital Nexus Fund, L.P. (the "Nexus Fund"), and a separately managed account (the "Account"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 22:16 UTC |
RA CAPITAL MANAGEMENT, L.P.Director · 10% owner
RA Capital Healthcare Fund LPDirector · 10% owner
RA Capital Nexus Fund, L.P.Director · 10% owner
Kolchinsky PeterDirector · 10% owner
Shah Rajeev M.Director · 10% owner
|
GrantCommon Stock | 3,180,155 | $13.01 | $41,373,816.55 |
DisclosureSEC source: 0001415889-24-003043 · form4-02082024_100255.xml · nonDerivative · entry 1 RA CAPITAL MANAGEMENT, L.P. · CIK 0001346824 · Director · 10% owner RA Capital Healthcare Fund LP · CIK 0001315082 · Director · 10% owner RA Capital Nexus Fund, L.P. · CIK 0001780117 · Director · 10% owner Kolchinsky Peter · CIK 0001384859 · Director · 10% owner Shah Rajeev M. · CIK 0001619841 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 8,477,275 F1 · ownership.nature: These securities are held directly by RA Capital Healthcare Fund, L.P. (the "Fund"). F2 · ownership.nature: RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund, RA Capital Nexus Fund, L.P. (the "Nexus Fund"), and a separately managed account (the "Account"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 01:22 UTC |
Harris ToddDirector · President and CEO
|
SaleCommon Stock | 13,817 | $16.97 | $234,430.28 |
DisclosureSEC source: 0000950170-24-011879 · ownership.xml · nonDerivative · entry 3 Harris Todd · CIK 0001711463 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,502,697 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022. F4 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.51 to $17.32. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| February 02, 2024 Filed Feb 7, 2024 01:23 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,393 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0000950170-24-011880 · ownership.xml · derivative · entry 5 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,110 Underlying: Common Stock · 25,393 shares Expires 2030-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| February 02, 2024 Filed Feb 7, 2024 01:23 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 2,300 | $17.04 | $39,198.90 |
DisclosureSEC source: 0000950170-24-011880 · ownership.xml · nonDerivative · entry 3 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 477,981 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022. F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.00 to $17.17. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| February 02, 2024 Filed Feb 7, 2024 01:23 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 73,093 | $16.31 | $1,191,898.31 |
DisclosureSEC source: 0000950170-24-011880 · ownership.xml · nonDerivative · entry 2 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 480,281 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.91. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| February 02, 2024 Filed Feb 7, 2024 01:23 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionCommon Stock | 25,393 | $0.61 | $15,489.73 |
DisclosureSEC source: 0000950170-24-011880 · ownership.xml · nonDerivative · entry 1 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 553,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2024 Filed Feb 7, 2024 01:22 UTC |
Harris ToddDirector · President and CEO
|
SaleCommon Stock | 7,187 | $17.04 | $122,494.51 |
DisclosureSEC source: 0000950170-24-011879 · ownership.xml · nonDerivative · entry 2 Harris Todd · CIK 0001711463 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,516,514 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022. F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.00 to $17.16. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| February 02, 2024 Filed Feb 7, 2024 01:22 UTC |
Harris ToddDirector · President and CEO
|
SaleCommon Stock | 78,996 | $16.45 | $1,299,160.32 |
DisclosureSEC source: 0000950170-24-011879 · ownership.xml · nonDerivative · entry 1 Harris Todd · CIK 0001711463 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,523,701 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.9995. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 23:37 UTC |
Tada HiroomiChief Medical Officer
|
GrantCommon Stock | 1,337 | $6.58 | $8,796.12 |
DisclosureSEC source: 0001209191-23-050094 · doc4.xml · nonDerivative · entry 1 Tada Hiroomi · CIK 0001880593 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,467 F1 · kind: These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 23:36 UTC |
Harris ToddDirector · President and CEO
|
GrantCommon Stock | 1,421 | $6.58 | $9,348.76 |
DisclosureSEC source: 0001209191-23-050092 · doc4.xml · nonDerivative · entry 1 Harris Todd · CIK 0001711463 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,602,697 F1 · kind: These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 23:27 UTC |
Fuhrman AlanChief Financial Officer
|
GrantCommon Stock | 1,463 | $12.50 | $18,292.62 |
DisclosureSEC source: 0001209191-23-050090 · doc4.xml · nonDerivative · entry 1 Fuhrman Alan · CIK 0001303521 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,463 F1 · kind: These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| July 28, 2023 Filed Aug 1, 2023 21:41 UTC |
Tada HiroomiChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 115,000 | $0.00 Strike: $14.35 | $0.00 |
DisclosureSEC source: 0001209191-23-044047 · doc4.xml · derivative · entry 1 Tada Hiroomi · CIK 0001880593 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 115,000 shares Expires 2033-07-27 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly following July 28, 2023, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date. Read SEC document |
| July 28, 2023 Filed Aug 1, 2023 21:38 UTC |
Harris ToddDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 330,000 | $0.00 Strike: $14.35 | $0.00 |
DisclosureSEC source: 0001209191-23-044044 · doc4.xml · derivative · entry 1 Harris Todd · CIK 0001711463 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,000 Underlying: Common Stock · 330,000 shares Expires 2033-07-27 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly following July 28, 2023, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date. Read SEC document |
| July 28, 2023 Filed Aug 1, 2023 21:34 UTC |
Fuhrman AlanChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 62,685 | $0.00 Strike: $14.35 | $0.00 |
DisclosureSEC source: 0001209191-23-044035 · doc4.xml · derivative · entry 1 Fuhrman Alan · CIK 0001303521 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,685 Underlying: Common Stock · 62,685 shares Expires 2033-07-27 F1 · derivative.exercise_date: 25% of the shares subject to the option will vest on July 28, 2024, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date. Read SEC document |
| July 28, 2023 Filed Aug 1, 2023 21:30 UTC |
Bensen DanielChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 110,000 | $0.00 Strike: $14.35 | $0.00 |
DisclosureSEC source: 0001209191-23-044027 · doc4.xml · derivative · entry 1 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2033-07-27 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly following July 28, 2023, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date. Read SEC document |
| July 21, 2023 Filed Jul 22, 2023 00:52 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,900 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-23-043165 · doc4.xml · derivative · entry 6 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,503 Underlying: Common Stock · 3,900 shares Expires 2030-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| July 21, 2023 Filed Jul 22, 2023 00:52 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 3,900 | $16.01 | $62,427.69 |
DisclosureSEC source: 0001209191-23-043165 · doc4.xml · nonDerivative · entry 4 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 527,981 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.07. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| July 21, 2023 Filed Jul 22, 2023 00:52 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionCommon Stock | 3,900 | $0.61 | $2,379.00 |
DisclosureSEC source: 0001209191-23-043165 · doc4.xml · nonDerivative · entry 3 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 531,881 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 19, 2023 Filed Jul 22, 2023 00:52 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 207 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-23-043165 · doc4.xml · derivative · entry 5 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 137,403 Underlying: Common Stock · 207 shares Expires 2030-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| July 19, 2023 Filed Jul 22, 2023 00:52 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 207 | $16.08 | $3,327.53 |
DisclosureSEC source: 0001209191-23-043165 · doc4.xml · nonDerivative · entry 2 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 527,981 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022. Read SEC document |
| July 19, 2023 Filed Jul 22, 2023 00:52 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionCommon Stock | 207 | $0.61 | $126.27 |
DisclosureSEC source: 0001209191-23-043165 · doc4.xml · nonDerivative · entry 1 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 528,188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 17, 2023 Filed Jul 17, 2023 23:35 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,900 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-23-042495 · doc4.xml · derivative · entry 6 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 137,610 Underlying: Common Stock · 1,900 shares Expires 2030-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| July 17, 2023 Filed Jul 17, 2023 23:35 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 1,900 | $16.03 | $30,464.03 |
DisclosureSEC source: 0001209191-23-042495 · doc4.xml · nonDerivative · entry 4 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 527,981 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022. F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.10. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| July 17, 2023 Filed Jul 17, 2023 23:35 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionCommon Stock | 1,900 | $0.61 | $1,159.00 |
DisclosureSEC source: 0001209191-23-042495 · doc4.xml · nonDerivative · entry 3 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 529,881 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 23:35 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 500 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-23-042495 · doc4.xml · derivative · entry 5 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 139,510 Underlying: Common Stock · 500 shares Expires 2030-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 23:35 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 500 | $16.13 | $8,065.00 |
DisclosureSEC source: 0001209191-23-042495 · doc4.xml · nonDerivative · entry 2 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 527,981 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.05 and $16.25. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 23:35 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionCommon Stock | 500 | $0.61 | $305.00 |
DisclosureSEC source: 0001209191-23-042495 · doc4.xml · nonDerivative · entry 1 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 528,481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 12, 2023 Filed Jul 12, 2023 22:41 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 201 | $16.23 | $3,262.31 |
DisclosureSEC source: 0001209191-23-042114 · doc4.xml · nonDerivative · entry 6 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 527,981 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022. F4 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.07 to $16.39. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| July 12, 2023 Filed Jul 12, 2023 22:41 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionCommon Stock | 201 | $0.61 | $122.61 |
DisclosureSEC source: 0001209191-23-042114 · doc4.xml · nonDerivative · entry 5 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 528,182 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 11, 2023 Filed Jul 12, 2023 22:41 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 201 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-23-042114 · doc4.xml · derivative · entry 9 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,010 Underlying: Common Stock · 201 shares Expires 2030-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| July 11, 2023 Filed Jul 12, 2023 22:41 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 500 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-23-042114 · doc4.xml · derivative · entry 8 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,211 Underlying: Common Stock · 500 shares Expires 2030-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| July 11, 2023 Filed Jul 12, 2023 22:41 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 500 | $16.02 | $8,009.50 |
DisclosureSEC source: 0001209191-23-042114 · doc4.xml · nonDerivative · entry 4 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 527,981 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022. F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.06. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| July 11, 2023 Filed Jul 12, 2023 22:41 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionCommon Stock | 500 | $0.61 | $305.00 |
DisclosureSEC source: 0001209191-23-042114 · doc4.xml · nonDerivative · entry 3 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 528,481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 10, 2023 Filed Jul 12, 2023 22:41 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,202 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-23-042114 · doc4.xml · derivative · entry 7 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,711 Underlying: Common Stock · 1,202 shares Expires 2030-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| July 10, 2023 Filed Jul 12, 2023 22:41 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 1,202 | $16.01 | $19,240.29 |
DisclosureSEC source: 0001209191-23-042114 · doc4.xml · nonDerivative · entry 2 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 527,981 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.12. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| July 10, 2023 Filed Jul 12, 2023 22:41 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionCommon Stock | 1,202 | $0.61 | $733.22 |
DisclosureSEC source: 0001209191-23-042114 · doc4.xml · nonDerivative · entry 1 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 529,183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 03, 2023 Filed Jul 3, 2023 21:31 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,265 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-23-040654 · doc4.xml · derivative · entry 10 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,913 Underlying: Common Stock · 4,265 shares Expires 2030-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| July 03, 2023 Filed Jul 3, 2023 21:31 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 400 | $17.04 | $6,814.00 |
DisclosureSEC source: 0001209191-23-040654 · doc4.xml · nonDerivative · entry 7 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 527,981 F5 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.02 to $17.05. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| July 03, 2023 Filed Jul 3, 2023 21:31 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 3,865 | $16.30 | $62,999.89 |
DisclosureSEC source: 0001209191-23-040654 · doc4.xml · nonDerivative · entry 6 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 528,381 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022. F4 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16 to $17. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| July 03, 2023 Filed Jul 3, 2023 21:31 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionCommon Stock | 4,265 | $0.61 | $2,601.65 |
DisclosureSEC source: 0001209191-23-040654 · doc4.xml · nonDerivative · entry 5 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 532,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2023 Filed Jul 3, 2023 21:31 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 18,819 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-23-040654 · doc4.xml · derivative · entry 9 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,178 Underlying: Common Stock · 18,819 shares Expires 2030-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 30, 2023 Filed Jul 3, 2023 21:31 UTC |
Bensen DanielChief Operating Officer
|
SaleCommon Stock | 18,819 | $16.97 | $319,418.65 |
DisclosureSEC source: 0001209191-23-040654 · doc4.xml · nonDerivative · entry 4 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 527,981 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022. F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.45 to $17.14. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Read SEC document |
| June 30, 2023 Filed Jul 3, 2023 21:31 UTC |
Bensen DanielChief Operating Officer
|
Exercise / conversionCommon Stock | 18,819 | $0.61 | $11,479.59 |
DisclosureSEC source: 0001209191-23-040654 · doc4.xml · nonDerivative · entry 3 Bensen Daniel · CIK 0001880946 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 546,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.